A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age-Reference-Cited by-同舟云学术

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age

Published:2017-06 Issue:30 Volume:35 Page:3749-3759
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

August Allison,Glenn Gregory M.,Kpamegan Eloi,Hickman Somia P.,Jani Dewal,Lu Hanxin,Thomas D. Nigel,Wen Judy,Piedra Pedro A.,Fries Louis F.

Funder

Novavax

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010

2. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid;Boyce;J Pediatr,2000

3. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006;Stockman;Pediatr Infect Dis J,2012

4. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age;Hall;Pediatrics,2013

5. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of fetal and early life infections through maternal-neonatal immunization;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Global progress in clinical research on human respiratory syncytial virus vaccines;Frontiers in Microbiology;2024-09-02

3. Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates;Vaccines;2024-08-28

4. Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants;Journal of the Pediatric Infectious Diseases Society;2024-07-12

5. Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses;Viruses;2024-06-09